|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.160 EUR | 0.00% |
|
+2.97% | +12.43% |
| 05-05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 198M 226M 182M 168M 317M 21.78B 324M 2.18B 857M 10.66B 849M 831M 36.71B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 198M 226M 182M 168M 317M 21.78B 324M 2.18B 857M 10.66B 849M 831M 36.71B | EV / Sales 2026 * |
0.25x | EV / Sales 2027 * | 0.25x |
| Free-Float |
12.27% | Yield 2026 * |
0.96% | Yield 2027 * | 0.96% |
| 1 week | +2.97% | ||
| Current month | +5.05% | ||
| 1 month | +1.96% | ||
| 3 months | +20.93% | ||
| 6 months | +4.52% | ||
| Current year | +12.43% |
| 1 week | 4.04 |  | 4.2 |
| 1 month | 3.9 | | 4.2 |
| Current year | 3.22 | | 4.26 |
| 1 year | 2.86 | | 4.26 |
| 3 years | 2.28 | | 4.26 |
| 5 years | 2.28 | | 4.26 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 31/12/2002 |
Michael Bock
BRD | Director/Board Member | 63 | 24/05/2005 |
| Director/Board Member | 63 | 19/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +2.97% | +41.50% | +36.84% | 226M | |
| -0.35% | +2.16% | +30.37% | +45.55% | 18.51B | |
| -0.70% | -0.22% | +20.04% | +70.66% | 13.26B | |
| -3.66% | +6.11% | -29.37% | -54.55% | 12.33B | |
| -0.25% | +1.07% | +2.08% | +66.83% | 11.16B | |
| -0.93% | +1.40% | +22.47% | +87.81% | 10.02B | |
| +0.51% | +1.03% | -6.64% | -29.01% | 9.28B | |
| -1.11% | +0.11% | +19.78% | +191.22% | 7.55B | |
| +1.13% | +0.42% | +12.70% | -23.56% | 6.86B | |
| -0.89% | -1.33% | -25.67% | - | 6.81B | |
| Average | -0.62% | +1.65% | +8.73% | +43.53% | 9.6B | |
| Weighted average by Cap. | -0.78% | +1.79% | +7.54% | +42.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 901M 727M 670M 1.26B 86.78B 1.29B 8.69B 3.42B 42.5B 3.38B 3.31B 146B | 803M 919M 741M 683M 1.29B 88.51B 1.32B 8.86B 3.48B 43.35B 3.45B 3.38B 149B |
| Net income | 36.66M 41.95M 33.83M 31.18M 58.78M 4.04B 60.08M 404M 159M 1.98B 158M 154M 6.81B | 38.2M 43.71M 35.25M 32.49M 61.23M 4.21B 62.59M 421M 166M 2.06B 164M 161M 7.1B |
| Net Debt | - | - |
Employees
7,416
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | €4.160 | 0.00% | 100 |
| 16/07/26 | €4.160 | +0.97% | 2,195 |
| 15/07/26 | €4.120 | +0.49% | 4,732 |
| 14/07/26 | €4.100 | +0.49% | 902 |
| 13/07/26 | €4.080 | +0.99% | 2,865 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.160EUR
Average target price
7.300EUR
Spread / Average Target
+75.48%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
